Published in Diabetes Care on January 01, 2000
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.56
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes (2009) 1.55
CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med (2008) 1.45
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23
Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit (2011) 1.14
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care (2009) 1.09
A1c variability can predict coronary artery disease in patients with type 2 diabetes with mean a1c levels greater than 7. Endocrinol Metab (Seoul) (2013) 0.99
The median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus. J Diabetes Sci Technol (2009) 0.97
Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care (2013) 0.96
Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proc Natl Acad Sci U S A (2015) 0.95
Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care (2009) 0.93
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine. Diabetes Technol Ther (2009) 0.93
Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study. BMC Med (2014) 0.88
Glycemic variability: Clinical implications. Indian J Endocrinol Metab (2013) 0.87
Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol (2008) 0.86
Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. Mol Pharm (2013) 0.86
HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis. PLoS One (2014) 0.85
Glycemic Variability: How Do We Measure It and Why Is It Important? Diabetes Metab J (2015) 0.85
On the potential of acarbose to reduce cardiovascular disease. Cardiovasc Diabetol (2014) 0.84
A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China. Diabetes Metab Res Rev (2012) 0.84
Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin. Int J Endocrinol (2015) 0.83
Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction. Cardiovasc Diabetol (2013) 0.83
The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells. J Diabetes Res (2014) 0.80
Intermittent high glucose enhances apoptosis in INS-1 cells. Exp Diabetes Res (2011) 0.79
Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes. Patient Prefer Adherence (2008) 0.79
Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care (2012) 0.79
The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus. J Diabetes Res (2013) 0.78
A four-year cardiovascular risk score for type 2 diabetic inpatients. PeerJ (2015) 0.78
Glucose time series complexity as a predictor of type 2 diabetes. Diabetes Metab Res Rev (2016) 0.78
4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary. Diabetes Technol Ther (2011) 0.78
Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus. J Diabetes Res (2016) 0.78
Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients? Korean Diabetes J (2010) 0.77
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira). Adv Ther (2015) 0.76
Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes. J Diabetes Res (2016) 0.76
Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study. J Diabetes Complications (2016) 0.76
Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy. Expert Rev Endocrinol Metab (2015) 0.75
Age-Based Differences in the Genetic Determinants of Glycemic Control: A Case of FOXO3 Variations. PLoS One (2015) 0.75
Acute hyperglycemia does not impair microvascular reactivity and endothelial function during hyperinsulinemic isoglycemic and hyperglycemic clamp in type 1 diabetic patients. Exp Diabetes Res (2012) 0.75
Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention. Diabetol Metab Syndr (2017) 0.75
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog. Clin Med Insights Endocrinol Diabetes (2010) 0.75
Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China. Sci Rep (2016) 0.75
Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria. J Control Release (2017) 0.75
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes (1998) 3.55
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab (1989) 2.07
Endocarditis caused by Rochalimaea henselae. Hum Pathol (1993) 1.99
Pandemic influenza A(H1N1)v: human to pig transmission in Norway? Euro Surveill (2009) 1.96
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med (2008) 1.91
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med (2004) 1.89
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care (2001) 1.84
Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis (1998) 1.78
Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet (2005) 1.74
FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet (2002) 1.63
Survival and disease complications in thalassemia major. Ann N Y Acad Sci (1998) 1.62
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest (2001) 1.59
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1991) 1.57
Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia (1995) 1.54
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A). Nucleic Acids Res (1997) 1.51
Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol (1998) 1.48
Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J (2011) 1.44
An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J (1998) 1.43
Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med (2005) 1.41
Life-threatening cytomegalovirus colitis in the immunocompetent patient: report of a case and review of the literature. Dis Colon Rectum (2001) 1.41
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia (2007) 1.40
Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J (1994) 1.37
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2011) 1.34
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.34
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest (1991) 1.31
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med (2005) 1.29
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J (2001) 1.26
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol (1992) 1.25
Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism (1983) 1.23
Periplasmic disulphide bond formation is essential for cellulase secretion by the plant pathogen Erwinia chrysanthemi. Mol Microbiol (1994) 1.23
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia (2000) 1.23
The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia (1995) 1.21
Prognostic significance of lymph node dissection in gastric cancer. Br J Surg (1996) 1.21
Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest (2006) 1.20
The cellulose-binding domains from Cellulomonas fimi beta-1, 4-glucanase CenC bind nitroxide spin-labeled cellooligosaccharides in multiple orientations. J Mol Biol (1999) 1.16
Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord (2003) 1.15
Serum uric acid and related factors in 500 hospitalized subjects. Metabolism (1996) 1.14
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care (1999) 1.14
Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation (1997) 1.12
Salmonid alphavirus (SAV) and pancreas disease (PD) in Atlantic salmon, Salmo salar L., in freshwater and seawater sites in Norway from 2006 to 2008. J Fish Dis (2010) 1.12
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia (2010) 1.12
Risk factors for pancreas disease (PD) outbreaks in farmed Atlantic salmon and rainbow trout in Norway during 2003-2007. Prev Vet Med (2009) 1.11
Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care (2000) 1.11
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med (2013) 1.10
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke (1998) 1.09
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation (1998) 1.08
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia (2012) 1.08
The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer (2002) 1.07
Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. Diabetes Care (1996) 1.06
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. Allergy (2004) 1.06
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest (1993) 1.06
Trends in Campylobacter incidence in broilers and humans in six European countries, 1997-2007. Prev Vet Med (2009) 1.05
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab (1996) 1.05
High-resolution breast tomography at high energy: a feasibility study of phase contrast imaging on a whole breast. Phys Med Biol (2012) 1.05
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med (1993) 1.04
Classification of lymph node metastases from carcinoma of the stomach: comparison of the old (1987) and new (1997) TNM systems. World J Surg (1999) 1.04
Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med (1987) 1.03
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care (2001) 1.03
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord (2003) 1.02
Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr (1998) 1.02
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. Am J Physiol (1996) 1.01
Measurement of abdominal fat with T1-weighted MR images. J Magn Reson Imaging (1992) 1.01
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes (1982) 1.01
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest (1999) 1.00
In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia. Diabetologia (1995) 1.00
Renal metabolism of C-peptide in man. J Clin Endocrinol Metab (1987) 1.00
Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy (2007) 1.00
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab (2004) 1.00
Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol (2000) 0.99
Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. J Clin Endocrinol Metab (2010) 0.98
Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care (2001) 0.98
Alteration of a single tryptophan residue of the cellulose-binding domain blocks secretion of the Erwinia chrysanthemi Cel5 cellulase (ex-EGZ) via the type II system. J Mol Biol (2000) 0.97